Overcoming drug resistance by enhancing apoptosis of tumor cells
- PMID: 19442052
- DOI: 10.2174/156800909788166600
Overcoming drug resistance by enhancing apoptosis of tumor cells
Abstract
Drug resistance remains a major clinical challenge for cancer treatment. One mechanism by which tumor cells develop resistance to cytotoxic agents and radiation is related to resistance to apoptosis. Apoptosis is a well-organised process of cell death pre-programmed inside the cell. Apoptosis can be initiated either by activation of death receptors on the cell surface membranes (extrinsic pathway) or through a series of cellular events primarily processed at mitochondria (intrinsic pathway). Apoptosis has been shown to be important for tumorigenesis and cancer treatment. Defects in apoptosis can result in the expansion of a population of neoplastic cells. However, because the death of tumor cells induced by chemotherapy and radiotherapy is largely mediated by activation of apoptosis, inhibition of apoptosis will make tumor cells resistant to anti-tumor treatment. Herein, we will review the molecular changes that have the potential to cause apoptotic dysregulation, including activation of antiapoptotic factors (Bcl-2, BCLX(L), Bfl1/A1 etc.), inactivation of pro-apoptotic effectors (p53, p53 pathway), and /or reinforcement of survival signals (Survivin, FLIP, NF-kappaB etc). Furthermore, we will discuss therapeutic intervention and/or strategies that can lower the threshold for apoptosis of tumor cells that could became useful approaches to treat cancer with special emphasis placed on the important priority to develop new cancer therapeutics toward tumor stem cells.
Similar articles
-
Modification of gene products involved in resistance to apoptosis in metastatic colon cancer cells: roles of Fas, Apaf-1, NFkappaB, IAPs, Smac/DIABLO, and AIF.J Surg Res. 2007 Sep;142(1):184-94. doi: 10.1016/j.jss.2006.12.551. Epub 2007 Jul 2. J Surg Res. 2007. PMID: 17603079
-
Down-regulation of intracellular anti-apoptotic proteins, particularly c-FLIP by therapeutic agents; the novel view to overcome resistance to TRAIL.J Cell Physiol. 2018 Oct;233(10):6470-6485. doi: 10.1002/jcp.26585. Epub 2018 May 9. J Cell Physiol. 2018. PMID: 29741767 Review.
-
Cancer and Apoptosis.Methods Mol Biol. 2022;2543:191-210. doi: 10.1007/978-1-0716-2553-8_16. Methods Mol Biol. 2022. PMID: 36087269
-
Multifaceted targeting in cancer: the recent cell death players meet the usual oncogene suspects.Expert Opin Ther Targets. 2007 May;11(5):641-59. doi: 10.1517/14728222.11.5.641. Expert Opin Ther Targets. 2007. PMID: 17465723 Review.
-
Sensitization of tumor cells to Apo2 ligand/TRAIL-induced apoptosis by inhibition of casein kinase II.Cancer Res. 2002 Aug 1;62(15):4180-5. Cancer Res. 2002. PMID: 12154014
Cited by
-
Association of the genetic diversity of killer cell immunoglobulin-like receptor genes and HLA-C ligand in Saudi women with breast cancer.Immunogenetics. 2017 Feb;69(2):69-76. doi: 10.1007/s00251-016-0950-x. Epub 2016 Sep 15. Immunogenetics. 2017. PMID: 27631728
-
Serum vitamin D levels of patients with oral squamous cell carcinoma (OSCC) and expression of vitamin D receptor in oral precancerous lesions and OSCC.Med Oral Patol Oral Cir Bucal. 2015 Mar 1;20(2):e188-95. doi: 10.4317/medoral.20368. Med Oral Patol Oral Cir Bucal. 2015. PMID: 25662556 Free PMC article.
-
Anemoside B4 sensitizes human colorectal cancer to fluorouracil-based chemotherapy through src-mediated cell apoptosis.Aging (Albany NY). 2021 Dec 10;13(23):25365-25376. doi: 10.18632/aging.203751. Epub 2021 Dec 10. Aging (Albany NY). 2021. PMID: 34890366 Free PMC article.
-
Trans-3,5,4´-trimethoxystilbene reduced gefitinib resistance in NSCLCs via suppressing MAPK/Akt/Bcl-2 pathway by upregulation of miR-345 and miR-498.J Cell Mol Med. 2019 Apr;23(4):2431-2441. doi: 10.1111/jcmm.14086. Epub 2019 Jan 30. J Cell Mol Med. 2019. PMID: 30701693 Free PMC article.
-
Microarray-based detection and expression analysis of drug resistance in an animal model of peritoneal metastasis from colon cancer.Clin Exp Metastasis. 2024 Oct;41(5):707-715. doi: 10.1007/s10585-024-10283-5. Epub 2024 Apr 12. Clin Exp Metastasis. 2024. PMID: 38609535 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous